PHARMA BASE
ActiveSummary
The computed 12-month bankruptcy probability of PHARMA BASE is 3.4% (moderate). The 2024 annual accounts show equity of €2.5m and a net result of €178,876. Equity remains stable across the filed financial years (±2.4% per year). Its solvency ranks better than 16% of 6,072 sector peers (NACE 46, financial year 2024). The company has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2025
23-06
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-07
NBB filing
Annual accounts filed
financial year 2023 · full format
2023
31-12
Financial
Weakest financial yearnet €41,833 ▼71.6%
Net result drops to €41,833, the lowest in the series; recovery starts the following year.
11-07
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
22-06
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
24-06
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
16-07
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
11-07
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
19-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
09-10
NBB filing
Annual accounts filed
financial year 2016 · full format · 70 days late
2016
04-07
NBB filing
Annual accounts filed
financial year 2015 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 40 annual accounts filed, the latest 10 are here; all 40 are at the National Bank.
0 of 21 deeds read
About the unread acts
We know of 21 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.